2-(Adamantan-1-yl)acetonitrile

Catalog No.: 
ACRQVS874
CAS No.: 
16269-13-9
Molecular Formula: 
C12H17N
Molecular Weight: 
175.27
2-(Adamantan-1-yl)acetonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$194.00InquiryInquiry
1g95%$466.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Adamantan-1-yl)acetonitrile
IUPAC Name2-(adamantan-1-yl)acetonitrile
MDL No.MFCD00194034
Molecular FormulaC12H17N
Molecular Weight175.27
SMILESN#CCC12CC3CC(C2)CC(C3)C1
InChI KeyDXQVPXCZIRQITG-UHFFFAOYSA-N
Synonym1-(Cyanomethyl)adamantane;2-(adaMantan-1-yl)acetonitrile;LABOTEST-BB LT00233105;IFLAB-BB F1928-0023;AKOS BB-9584;2-(1-ADAMANTYL)ACETONITRILE;1-ADAMANTANEACETONITRILE;1-ADAMANTYLACETONITRILE
CAS No.16269-13-9

Safety Data

Pictogram
ToxicHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H312-H315-H319-H331-H335
Precautionary Statement(s)
P261-P280-P304+P340-P305+P351+P338-P405-P501

Synthetic Route by SureRoute

1. ACRQVS874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQGTC501 route compound structure diagram
    ACQGTC50114651-42-4In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACRQVS874 route product structure diagram
    ACRQVS87416269-13-9
Inquiry

2. ACRQVS874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACRQVS874 route product structure diagram
    ACRQVS87416269-13-9
Inquiry

3. ACRQVS874 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRQVS874 route product structure diagram
    ACRQVS87416269-13-9
Inquiry

Comments (0)